230 related articles for article (PubMed ID: 25827531)
1. Immune evasion activities of accessory proteins Vpu, Nef and Vif are conserved in acute and chronic HIV-1 infection.
Mlcochova P; Apolonia L; Kluge SF; Sridharan A; Kirchhoff F; Malim MH; Sauter D; Gupta RK
Virology; 2015 Aug; 482():72-8. PubMed ID: 25827531
[TBL] [Abstract][Full Text] [Related]
2. HIV-1 accessory proteins--ensuring viral survival in a hostile environment.
Malim MH; Emerman M
Cell Host Microbe; 2008 Jun; 3(6):388-98. PubMed ID: 18541215
[TBL] [Abstract][Full Text] [Related]
3. Comparison of HIV-1 Vif and Vpu accessory proteins for delivery of polyepitope constructs harboring Nef, Gp160 and P24 using various cell penetrating peptides.
Kardani K; Hashemi A; Bolhassani A
PLoS One; 2019; 14(10):e0223844. PubMed ID: 31671105
[TBL] [Abstract][Full Text] [Related]
4. Multilayered and versatile inhibition of cellular antiviral factors by HIV and SIV accessory proteins.
Sauter D; Kirchhoff F
Cytokine Growth Factor Rev; 2018 Apr; 40():3-12. PubMed ID: 29526437
[TBL] [Abstract][Full Text] [Related]
5. Making Sense of Multifunctional Proteins: Human Immunodeficiency Virus Type 1 Accessory and Regulatory Proteins and Connections to Transcription.
Faust TB; Binning JM; Gross JD; Frankel AD
Annu Rev Virol; 2017 Sep; 4(1):241-260. PubMed ID: 28961413
[TBL] [Abstract][Full Text] [Related]
6. HLA Class I Downregulation by HIV-1 Variants from Subtype C Transmission Pairs.
Ende Z; Deymier MJ; Claiborne DT; Prince JL; Mónaco DC; Kilembe W; Allen SA; Hunter E
J Virol; 2018 Apr; 92(7):. PubMed ID: 29321314
[TBL] [Abstract][Full Text] [Related]
7. Distinct Requirements for HIV-1 Accessory Proteins during Cell Coculture and Cell-Free Infection.
Zotova A; Atemasova A; Pichugin A; Filatov A; Mazurov D
Viruses; 2019 Apr; 11(5):. PubMed ID: 31027334
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity of a novel DNA vaccine cassette expressing multiple human immunodeficiency virus (HIV-1) accessory genes.
Ayyavoo V; Kudchodkar S; Ramanathan MP; Le P; Muthumani K; Megalai NM; Dentchev T; Santiago-Barrios L; Mrinalini C; Weiner DB
AIDS; 2000 Jan; 14(1):1-9. PubMed ID: 10714562
[TBL] [Abstract][Full Text] [Related]
9. HIV-1 Nef and Vpu Interfere with L-Selectin (CD62L) Cell Surface Expression To Inhibit Adhesion and Signaling in Infected CD4+ T Lymphocytes.
Vassena L; Giuliani E; Koppensteiner H; Bolduan S; Schindler M; Doria M
J Virol; 2015 May; 89(10):5687-700. PubMed ID: 25822027
[TBL] [Abstract][Full Text] [Related]
10. Vpu-Mediated Counteraction of Tetherin Is a Major Determinant of HIV-1 Interferon Resistance.
Kmiec D; Iyer SS; Stürzel CM; Sauter D; Hahn BH; Kirchhoff F
mBio; 2016 Aug; 7(4):. PubMed ID: 27531907
[TBL] [Abstract][Full Text] [Related]
11. Dual regulation of L-selectin (CD62L) by HIV-1: Enhanced expression by Vpr in contrast with cell-surface down-modulation by Nef and Vpu.
Giuliani E; Vassena L; Galardi S; Michienzi A; Desimio MG; Doria M
Virology; 2018 Oct; 523():121-128. PubMed ID: 30119013
[TBL] [Abstract][Full Text] [Related]
12. Detection of the HIV-1 Accessory Proteins Nef and Vpu by Flow Cytometry Represents a New Tool to Study Their Functional Interplay within a Single Infected CD4
Prévost J; Richard J; Gasser R; Medjahed H; Kirchhoff F; Hahn BH; Kappes JC; Ochsenbauer C; Duerr R; Finzi A
J Virol; 2022 Mar; 96(6):e0192921. PubMed ID: 35080425
[TBL] [Abstract][Full Text] [Related]
13. HIV-1 Nef and Vpu are functionally redundant broad-spectrum modulators of cell surface receptors, including tetraspanins.
Haller C; Müller B; Fritz JV; Lamas-Murua M; Stolp B; Pujol FM; Keppler OT; Fackler OT
J Virol; 2014 Dec; 88(24):14241-57. PubMed ID: 25275127
[TBL] [Abstract][Full Text] [Related]
14. Activities of transmitted/founder and chronic clade B HIV-1 Vpu and a C-terminal polymorphism specifically affecting virion release.
Jafari M; Guatelli J; Lewinski MK
J Virol; 2014 May; 88(9):5062-78. PubMed ID: 24574397
[TBL] [Abstract][Full Text] [Related]
15. Innate Invariant NKT Cell Recognition of HIV-1-Infected Dendritic Cells Is an Early Detection Mechanism Targeted by Viral Immune Evasion.
Paquin-Proulx D; Gibbs A; Bächle SM; Checa A; Introini A; Leeansyah E; Wheelock CE; Nixon DF; Broliden K; Tjernlund A; Moll M; Sandberg JK
J Immunol; 2016 Sep; 197(5):1843-51. PubMed ID: 27481843
[TBL] [Abstract][Full Text] [Related]
16. HIV accessory proteins versus host restriction factors.
Strebel K
Curr Opin Virol; 2013 Dec; 3(6):692-9. PubMed ID: 24246762
[TBL] [Abstract][Full Text] [Related]
17. Transmitted/Founder HIV-1 Subtype C Viruses Show Distinctive Signature Patterns in Vif, Vpr, and Vpu That Are Under Subsequent Immune Pressure During Early Infection.
Rossenkhan R; MacLeod IJ; Brumme ZL; Magaret CA; Sebunya TK; Musonda R; Gashe BA; Edlefsen PT; Novitsky V; Essex M
AIDS Res Hum Retroviruses; 2016; 32(10-11):1031-1045. PubMed ID: 27349335
[TBL] [Abstract][Full Text] [Related]
18. Role of viral regulatory and accessory proteins in HIV-1 replication.
Seelamgari A; Maddukuri A; Berro R; de la Fuente C; Kehn K; Deng L; Dadgar S; Bottazzi ME; Ghedin E; Pumfery A; Kashanchi F
Front Biosci; 2004 Sep; 9():2388-413. PubMed ID: 15353294
[TBL] [Abstract][Full Text] [Related]
19. The human immunodeficiency virus type 1 Nef and Vpu proteins downregulate the natural killer cell-activating ligand PVR.
Matusali G; Potestà M; Santoni A; Cerboni C; Doria M
J Virol; 2012 Apr; 86(8):4496-504. PubMed ID: 22301152
[TBL] [Abstract][Full Text] [Related]
20. Remodeling of the Host Cell Plasma Membrane by HIV-1 Nef and Vpu: A Strategy to Ensure Viral Fitness and Persistence.
Sugden SM; Bego MG; Pham TN; Cohen ÉA
Viruses; 2016 Mar; 8(3):67. PubMed ID: 26950141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
